Evidence map›Paper›PMID 24021575›Full record

ArticleThe journal of pain2013

Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury.

Masaru Yoshizumi, James C Eisenach, Ken-ichiro Hayashida

Open access · greenAbstract read
In one paragraph

Article in The journal of pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Epigenetic regulation of persistent pain.Translational research : the journal of laboratory and clinical medicine · 2015
    Review
  10. Therapeutic potential of targeting glutamate receptors in Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2014
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Masaru YoshizumiDepartment of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
James C Eisenach
Ken-ichiro Hayashida
Wake Forest University · US

Funding

Mechanisms and Consequences of Locus Coeruleus ActivationR01DA027690 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HAYASHIDA, KENICHIRO · 2010 to 2014
$1.4M
NIDA NIH HHS DA27690NIDA NIH HHS R01 DA027690
6 · The paper itself

Abstract

unlabelledThe present study examined whether the histone deacetylase inhibitor valproate prevents downregulation of glutamate transporters in the primary cultured astrocytes and in the spinal cord after L5-L6 spinal nerve ligation (SNL) and whether this action of valproate on spinal glutamate transporters prevents spinal glutamate dysregulation and development of hypersensitivity after SNL. In cultured astrocytes, valproate prevented downregulation of glutamate transporter-1 (GLT-1) and glutamate-aspartate transporter in a concentration-dependent manner. Repeated oral administration of valproate reduced the development of hypersensitivity and prevented the downregulation of spinal GLT-1 and glutamate-aspartate transporter expression in rats after SNL, but did not affect mechanical nociception and expression of those transporters in normal rats. Valproate's effects on hypersensitivity and spinal GLT-1 expression in SNL rats were blocked by intrathecal administration of the selective GLT-1 blocker dihydrokainic acid or the GLT-1 selective small interfering RNA (siRNA). Extracellular glutamate concentration in the spinal cord, measured by microdialysis, was increased in animals with SNL or after GLT-1 selective siRNA treatment, and valproate prevented the SNL-induced glutamate increase. These results suggest that valproate reduces the development of chronic pain after nerve injury in part by preventing downregulation of glutamate transporters, especially GLT-1, to maintain normal extracellular glutamate concentrations in the spinal cord. PERSPECTIVE: This study demonstrates that valproate prevents the downregulation of glutamate transporters in the spinal cord, which contributes in part to the development of chronic pain after nerve injury. Given clinical availability and established safety profiles, perioperative use of valproate should be tested to prevent chronic pain after surgery.

Indexed as

Amino Acid Transport System X-AGAnimalsAstrocytesDown-RegulationExcitatory Amino Acid Transporter 2Glutamic AcidHyperalgesiaMalePeripheral Nerve InjuriesRatsRats, Sprague-DawleySpinal CordValproic AcidAmino Acid Transport System X-AGExcitatory Amino Acid Transporter 2Glutamic AcidSlc1a2 protein, ratValproic Acidastrocytechronic painglutamate transporterspinal cordValproate

Identifiers

PMID24021575
PMCPMC3818435
OpenAlexW1994876918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.